BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.02B |
| 2 |
Apple
AAPL
|
+$2.03B |
| 3 |
Amazon
AMZN
|
+$1.93B |
| 4 |
Microsoft
MSFT
|
+$1.89B |
| 5 |
Uber
UBER
|
+$1.88B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$5.15B |
| 2 |
VMW
VMware, Inc
VMW
|
+$2.9B |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$2.56B |
| 4 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$1.72B |
| 5 |
Danaher
DHR
|
+$1.02B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.07% |
| 2 | Healthcare | 12.77% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.47% |
| 5 | Industrials | 8.98% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Puma Biotechnology
PBYI
$450M
| $6.69M | ﹤0.01% |
1,544,532
+68,821
| +5% | +$228K |
|
3502
Mammoth Energy Services
TUSK
$154M
| $6.68M | ﹤0.01% |
1,496,945
+120,935
| +9% | +$536K |
|
|
VNET
3503
VNET Group
VNET
$2.12B
| $6.51M | ﹤0.01% |
2,269,267
-130,699
| -5% | -$393K |
|
3504
PUT
Carnival Corporation Ltd
CCL
$38.9B
| $6.49M | ﹤0.01% |
+350,000
| New | +$5.08M |
|
3505
EVI Industries
EVI
$209M
| $6.47M | ﹤0.01% |
272,788
+19,026
| +7% | +$481K |
|
3506
Bank7 Corp
BSVN
$499M
| $6.47M | ﹤0.01% |
236,682
+34,104
| +17% | +$809K |
|
3507
iShares US Equity Factor ETF
LRGF
$3.74B
| $6.46M | ﹤0.01% |
133,773
+6,830
| +5% | +$308K |
|
3508
Citius Pharmaceuticals
CTXR
$20.1M
| $6.4M | ﹤0.01% |
338,313
+26,867
| +9% | +$510K |
|
|
KYNB
3509
Kyntra Bio
KYNB
$28.5M
| $6.39M | ﹤0.01% |
288,212
-33,216
| -10% | -$501K |
|
|
DNMR
3510
DELISTED
Danimer Scientific, Inc.
DNMR
| $6.37M | ﹤0.01% |
156,215
+10,079
| +7% | +$548K |
|
|
IGMS
3511
DELISTED
IGM Biosciences
IGMS
| $6.34M | ﹤0.01% |
762,470
-108,446
| -12% | -$630K |
|
|
ESPR
3512
DELISTED
Esperion Therapeutics
ESPR
| $6.32M | ﹤0.01% |
2,112,899
+145,020
| +7% | +$188K |
|
3513
Babcock & Wilcox
BW
$1.39B
| $6.32M | ﹤0.01% |
4,325,873
+282,686
| +7% | +$602K |
|
|
ASAI
3514
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
| $6.31M | ﹤0.01% |
456,420
+2,490
| +0.5% | +$31K |
|
3515
Design Therapeutics
DSGN
$901M
| $6.31M | ﹤0.01% |
2,380,242
-23,673
| -1% | -$54.2K |
|
|
PPTA
3516
Perpetua Resources
PPTA
$3.1B
| $6.28M | ﹤0.01% |
1,982,009
+154,916
| +8% | +$522K |
|
3517
AN2 Therapeutics
ANTX
$226M
| $6.27M | ﹤0.01% |
305,841
+263,679
| +625% | +$4.41M |
|
3518
Rentokil
RTO
$12.1B
| $6.21M | ﹤0.01% |
217,140
-61,870
| -22% | -$1.82M |
|
3519
Aclaris Therapeutics
ACRS
$863M
| $6.2M | ﹤0.01% |
5,905,872
+297,982
| +5% | +$909K |
|
|
RPT
3520
Rithm Property Trust
RPT
$101M
| $6.2M | ﹤0.01% |
194,832
-51,542
| -21% | -$1.59M |
|
3521
Cue Biopharma
CUE
$131M
| $6.17M | ﹤0.01% |
77,959
+6,994
| +10% | +$500K |
|
3522
Protalix BioTherapeutics
PLX
$190M
| $6.15M | ﹤0.01% |
3,457,734
+282,272
| +9% | +$439K |
|
3523
Companhia Siderúrgica Nacional
SID
$1.19B
| $6.15M | ﹤0.01% |
1,565,209
-1,832,167
| -54% | -$5.3M |
|
3524
Duluth Holdings
DLTH
$151M
| $6.15M | ﹤0.01% |
1,142,771
+85,520
| +8% | +$447K |
|
|
MAGN
3525
Magnera Corp
MAGN
$433M
| $6.14M | ﹤0.01% |
243,491
+12,229
| +5% | +$257K |
|
Similar funds
BlackRock's Q4 2023 Portfolio in Review
As of Q4 2023, BlackRock held 5,578 positions worth $3.92T, up 13% from $3.48T the previous quarter. Its ten largest holdings account for 22% of the portfolio.
BlackRock's Q4 2023 filing shows 129 new, 3,072 increased, 1,515 reduced and 203 closed positions. Its largest new stake was NCR Atleos: 8,735,537 shares worth $212M. The largest sale was Activision Blizzard, an estimated $5.15B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q4 2023 buy was NCR Atleos: 8,735,537 shares worth $212M.
- BlackRock added most to Broadcom in Q4 2023, an estimated $3.02B increase.
- BlackRock's biggest Q4 2023 reduction was Danaher, cutting an estimated $1.02B.
- BlackRock fully exited Activision Blizzard in Q4 2023, selling an estimated $5.15B.
- BlackRock's ten largest holdings make up 22% of its $3.92T portfolio in Q4 2023.
- BlackRock opened 129 new positions and closed 203 in Q4 2023.
- BlackRock's portfolio value rose 13% quarter-over-quarter to $3.92T.
Based on BlackRock's 13F filing for Q4 2023, filed 13 Feb 2024.